share_log

Delta 9 Cannabis Inc. (OTCMKTS:DLTNF) Sees Large Decrease in Short Interest

kopsource ·  Oct 2, 2022 19:42

Delta 9 Cannabis Inc. (OTCMKTS:DLTNF – Get Rating) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 4,500 shares, a decrease of 16.7% from the August 31st total of 5,400 shares. Based on an average daily trading volume, of 3,500 shares, the days-to-cover ratio is currently 1.3 days.

Delta 9 Cannabis Stock Performance

Shares of Delta 9 Cannabis stock remained flat at $0.08 on Friday. The stock had a trading volume of 11 shares, compared to its average volume of 16,066. The business's 50-day simple moving average is $0.12 and its 200-day simple moving average is $0.16. Delta 9 Cannabis has a 12 month low of $0.08 and a 12 month high of $0.35.

Get Delta 9 Cannabis alerts:

About Delta 9 Cannabis

(Get Rating)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products.

Read More

  • Get a free copy of the StockNews.com research report on Delta 9 Cannabis (DLTNF)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment